What is Prenetics?
Founded in 2014, Prenetics operates as a multifaceted health-tech organization with a primary focus on decentralizing medical services. The company provides a comprehensive suite of offerings, including consumer genetic testing, early colorectal cancer screening, and rapid point-of-care diagnostics. By utilizing proprietary mobile applications and advanced technological platforms, Prenetics bridges the gap between clinical-grade diagnostics and consumer accessibility. Its presence across key markets—including the United Kingdom, Hong Kong, India, South Africa, and Southeast Asia—positions it as a critical infrastructure provider in the global shift toward proactive, data-informed health management.
How much funding has Prenetics raised?
Prenetics has raised a total of $82.7M across 4 funding rounds:
Angel/Seed
$2.6M
Series A
$10M
Series B
$40M
Other Financing Round
$30M
Angel/Seed (2014): $2.7M with participation from 500.com, SXE Ventures, and Coent Venture Partners
Series A (2016): $10M led by 500.com, COENT Venture, Venturra, Ping An, Lippo Group, and Capital Union Investments
Series B (2017): $40M supported by Venturra, Ping An Ventures, and Beyond Ventures
Other Financing Round (2024): $30M featuring Insighta
Key Investors in Prenetics
500.com
A leading online service provider in China that was among the first to offer digital lottery services, backed by approval from the Ministry of Finance.
Venturra
A Southeast Asia-based venture capital firm that invests in early-stage, high-growth technology-enabled companies with the ambition to redefine their respective industries.
Ping An Ventures
The investment arm of a major personal financial services group specializing in insurance, banking, and investment banking, headquartered in Shenzhen.
What's next for Prenetics?
With the successful closure of this major strategic investment, Prenetics is well-positioned to accelerate its expansion into new diagnostic verticals and deepen its penetration in existing international markets. The capital will likely be deployed to enhance its technological stack, specifically focusing on the integration of AI-driven predictive analytics within its personalized care pillar. As the company continues to navigate the complexities of the global healthcare landscape, the focus remains on scaling its at-home diagnostic capabilities and fostering strategic partnerships that align with its long-term vision of making healthcare available to anyone, anytime, and anywhere.
See full Prenetics company page
